Volume Alert - JNJ 108.39 Johnson & Johnson $JNJ H
Post# of 129
Posted On: 11/17/2014 2:08:07 PM
Volume Alert - JNJ 108.39 Johnson & Johnson $JNJ Hit a high today of 108.69 Closing the day 10:30 at 108.39 +0.23 +0.21% With a day low of 107.61 and a total volume of 1,087,101.
JNJ Recent Posts: http://investorshangout.com/Johnson--Johnson-JNJ-51518/
JNJ Johnson & Johnson Recent Headline News
DexCom Still A Favorite Diabetes Stock
Bill Gunderson - at Seeking Alpha - 2 hrs 52 mins ago
DexCom (NASDAQ: DXCM ) continues to be one of my favorite diabetes stocks. DexCom, founded in 1999 and based right here in my hometown of San Diego, California, is a medical device company that makes continuous glucose monitoring (CGM) systems. ...
JNJ: 108.34 (+0.18), ABT: 43.84 (+0.03), DXCM: 52.03 (-0.70), MDT: 69.52 (+0.57)
Early Glance: Medical Devices companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.62 (+0.50), JNJ: 108.34 (+0.18), MDT: 69.52 (+0.57), BAX: 71.97 (+0.22)
Early Glance: Pharmaceuticals companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 108.34 (+0.18), BAX: 71.97 (+0.22), PFE: 30.31 (-0.03), BMY: 58.40 (+0.45)
5 Rocket Stocks to Buy as Earnings Season Ends: Southwest Airlines and More
at The Street - Mon Nov 17, 9:17AM CST
From a momentum standpoint, stocks are well-positioned to keep up their upside action as we head into the final stretch of 2014.
JNJ: 108.34 (+0.18), ORLY: 177.17 (-2.71), ED: 62.54 (+0.51), LUV: 39.33 (+0.38), CRM: 62.67 (-1.24)
Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
George Budwell, The Motley Fool - Motley Fool - Mon Nov 17, 7:13AM CST
As the healthcare sector rolls through its third-quarter earnings, a bucolic picture is coming into focus. Earnings across the sector are soaring due to new drug launches, a frenzy of acquisitions, and vast reorganizations that have helped to stem...
JNJ: 108.34 (+0.18), GILD: 100.39 (-1.67), ABBV: 65.09 (+1.09), CELG: 104.48 (+0.43)
Forget Marijuana! This Is a Much Smarter Investment
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 16, 11:11AM CST
Source: Flickr user Oswaldo. Although marijuana initiatives didn't log a perfect sweep in this year's midterm elections, the momentum behind the legalization movement remains intact. Two states (Oregon and Alaska), as well as Washington, D.C.,...
JNJ: 108.34 (+0.18), INSY: 38.15 (-0.42), GWPH: 75.35 (-0.28), GSK: 45.86 (+0.12), NVS: 94.50 (+0.55)
Value Investors' Most Loved Stocks In Q3 2014
Trading Mates Stock Advisor - at Seeking Alpha - Sun Nov 16, 8:09AM CST
NOV: 71.78 (+0.44), JNJ: 108.34 (+0.18), IBM: 164.69 (+0.53), WMT: 83.54 (+0.58), BAC: 17.08 (-0.06), BEN: 56.32 (-0.06), ACN: 84.58 (-0.06), SLB: 96.26 (+0.94), ORCL: 41.18 (+0.34)
3 Ways High-Yield Dividend Stocks Can Help You Recreate Warren Buffett's Investing Success
Adam Galas, The Motley Fool - Motley Fool - Sat Nov 15, 6:05PM CST
Many people consider Warren Buffett the greatest investor in history and it's not hard to understand why. According to a 2012 Yale study, Buffett's company, Berkshire Hathaway , had the best risk-adjusted return of any company or mutual fund that...
KMI: 40.10 (+0.73), MMM: 158.99 (+0.14), JNJ: 108.34 (+0.18), LNCO: 20.31 (-0.62), IBM: 164.69 (+0.53), WFC: 53.40 (+0.05), SDRL: 20.93 (+0.15), PG: 87.68 (-0.43), LINE: 22.34 (-0.31), VNR: 24.03 (-0.45), CL: 67.80 (+0.24)
Johnson & Johnson Part VI: 'Magic Pants' And 'Doubling Pennies'
Robert Honeywill - Seeking Alpha - Sat Nov 15, 6:00AM CST
In Part V of this series, I provided 4 scenarios (8 Cases) illustrating the potential financial outcomes for investors in Johnson & Johnson (NYSE: JNJ ) under changing PE ratios, which are a reflection of changing share prices and changing...
JNJ: 108.34 (+0.18)
Retirement Strategy: Annuities Vs. Dividend Growth Investing For A Lifetime Income
Regarded Solutions - at Seeking Alpha - Fri Nov 14, 11:01PM CST
KO: 42.86 (+0.13), T: 35.85 (-0.05), JNJ: 108.34 (+0.18), GE: 26.63 (+0.17), XOM: 94.83 (-0.26), MCD: 95.81 (-0.40), PG: 87.68 (-0.43), CVX: 115.91 (-0.41), AAPL: 113.90 (-0.28), WAG: 66.30 (-0.63)
Final Glance: Pharmaceuticals companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 108.34 (+0.18), BAX: 71.97 (+0.22), PFE: 30.31 (-0.03), BMY: 58.40 (+0.45)
Final Glance: Medical Devices companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.62 (+0.50), JNJ: 108.34 (+0.18), MDT: 69.52 (+0.57), BAX: 71.97 (+0.22)
Geron Collaborates with J&J for Imetelstat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:00PM CST
Geron Corporation (GERN), a clinical-stage biopharmaceutical company, announced that it has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc., a unit of Johnson & Johnson (JNJ).
BIIB: 304.41 (-1.02), JNJ: 108.34 (+0.18), GERN: 3.00 (+0.24), AFFX: 9.27 (-0.44)
Halliburton and Geron are big market movers
AP - Fri Nov 14, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
SINA: 39.51 (-0.29), AMZN: 321.91 (-5.91), JNJ: 108.34 (+0.18), HTZ: 22.10 (+0.41), GERN: 3.00 (+0.24), HAL: 49.59 (-5.49), JWN: 73.22 (-0.95), NOK: 7.67 (-0.19), BHI: 66.06 (+6.17)
Geron's Short Squeeze Is Here
Vahan Avetisyan - Seeking Alpha - Fri Nov 14, 2:40PM CST
Geron' s 2014 D eal to the Rescue Geron (NASDAQ: GERN ) surprised Thursday after-hours when it announced news that it entered into an exclusive worldwide license and collaboration agreement to develop its blood disorder drug imetelstat with...
JNJ: 108.34 (+0.18), GERN: 3.00 (+0.24)
Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:39PM CST
Mallinckrodt (MNK) received a setback when the FDA informed the company that its methylphenidate hydrochloride extended-release tablets, USP (CII) might not be therapeutically equivalent to Johnson & Johnson's (JNJ) Concerta.
MNK: 88.04 (-0.07), BIIB: 304.41 (-1.02), JNJ: 108.34 (+0.18), ACT: 247.01 (+3.24)
Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline
at The Street - Fri Nov 14, 2:36PM CST
U.S. stocks fluctuate on Friday, caught between better-than-expected retail sales and more worries of eurozone deflation.
SINA: 39.51 (-0.29), JNJ: 108.34 (+0.18), HTZ: 22.10 (+0.41), VA: 30.86 (+0.86), GERN: 3.00 (+0.24), JWN: 73.22 (-0.95)
Midday Glance: Pharmaceuticals companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
JNJ: 108.34 (+0.18), BAX: 71.97 (+0.22), PFE: 30.30 (-0.04), BMY: 58.40 (+0.45)
Midday Glance: Medical Devices companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.62 (+0.50), JNJ: 108.34 (+0.18), MDT: 69.52 (+0.57), BAX: 71.97 (+0.22)
JNJ Recent Posts: http://investorshangout.com/Johnson--Johnson-JNJ-51518/
JNJ Johnson & Johnson Recent Headline News
DexCom Still A Favorite Diabetes Stock
Bill Gunderson - at Seeking Alpha - 2 hrs 52 mins ago
DexCom (NASDAQ: DXCM ) continues to be one of my favorite diabetes stocks. DexCom, founded in 1999 and based right here in my hometown of San Diego, California, is a medical device company that makes continuous glucose monitoring (CGM) systems. ...
JNJ: 108.34 (+0.18), ABT: 43.84 (+0.03), DXCM: 52.03 (-0.70), MDT: 69.52 (+0.57)
Early Glance: Medical Devices companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.62 (+0.50), JNJ: 108.34 (+0.18), MDT: 69.52 (+0.57), BAX: 71.97 (+0.22)
Early Glance: Pharmaceuticals companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 108.34 (+0.18), BAX: 71.97 (+0.22), PFE: 30.31 (-0.03), BMY: 58.40 (+0.45)
5 Rocket Stocks to Buy as Earnings Season Ends: Southwest Airlines and More
at The Street - Mon Nov 17, 9:17AM CST
From a momentum standpoint, stocks are well-positioned to keep up their upside action as we head into the final stretch of 2014.
JNJ: 108.34 (+0.18), ORLY: 177.17 (-2.71), ED: 62.54 (+0.51), LUV: 39.33 (+0.38), CRM: 62.67 (-1.24)
Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
George Budwell, The Motley Fool - Motley Fool - Mon Nov 17, 7:13AM CST
As the healthcare sector rolls through its third-quarter earnings, a bucolic picture is coming into focus. Earnings across the sector are soaring due to new drug launches, a frenzy of acquisitions, and vast reorganizations that have helped to stem...
JNJ: 108.34 (+0.18), GILD: 100.39 (-1.67), ABBV: 65.09 (+1.09), CELG: 104.48 (+0.43)
Forget Marijuana! This Is a Much Smarter Investment
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 16, 11:11AM CST
Source: Flickr user Oswaldo. Although marijuana initiatives didn't log a perfect sweep in this year's midterm elections, the momentum behind the legalization movement remains intact. Two states (Oregon and Alaska), as well as Washington, D.C.,...
JNJ: 108.34 (+0.18), INSY: 38.15 (-0.42), GWPH: 75.35 (-0.28), GSK: 45.86 (+0.12), NVS: 94.50 (+0.55)
Value Investors' Most Loved Stocks In Q3 2014
Trading Mates Stock Advisor - at Seeking Alpha - Sun Nov 16, 8:09AM CST
NOV: 71.78 (+0.44), JNJ: 108.34 (+0.18), IBM: 164.69 (+0.53), WMT: 83.54 (+0.58), BAC: 17.08 (-0.06), BEN: 56.32 (-0.06), ACN: 84.58 (-0.06), SLB: 96.26 (+0.94), ORCL: 41.18 (+0.34)
3 Ways High-Yield Dividend Stocks Can Help You Recreate Warren Buffett's Investing Success
Adam Galas, The Motley Fool - Motley Fool - Sat Nov 15, 6:05PM CST
Many people consider Warren Buffett the greatest investor in history and it's not hard to understand why. According to a 2012 Yale study, Buffett's company, Berkshire Hathaway , had the best risk-adjusted return of any company or mutual fund that...
KMI: 40.10 (+0.73), MMM: 158.99 (+0.14), JNJ: 108.34 (+0.18), LNCO: 20.31 (-0.62), IBM: 164.69 (+0.53), WFC: 53.40 (+0.05), SDRL: 20.93 (+0.15), PG: 87.68 (-0.43), LINE: 22.34 (-0.31), VNR: 24.03 (-0.45), CL: 67.80 (+0.24)
Johnson & Johnson Part VI: 'Magic Pants' And 'Doubling Pennies'
Robert Honeywill - Seeking Alpha - Sat Nov 15, 6:00AM CST
In Part V of this series, I provided 4 scenarios (8 Cases) illustrating the potential financial outcomes for investors in Johnson & Johnson (NYSE: JNJ ) under changing PE ratios, which are a reflection of changing share prices and changing...
JNJ: 108.34 (+0.18)
Retirement Strategy: Annuities Vs. Dividend Growth Investing For A Lifetime Income
Regarded Solutions - at Seeking Alpha - Fri Nov 14, 11:01PM CST
KO: 42.86 (+0.13), T: 35.85 (-0.05), JNJ: 108.34 (+0.18), GE: 26.63 (+0.17), XOM: 94.83 (-0.26), MCD: 95.81 (-0.40), PG: 87.68 (-0.43), CVX: 115.91 (-0.41), AAPL: 113.90 (-0.28), WAG: 66.30 (-0.63)
Final Glance: Pharmaceuticals companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 108.34 (+0.18), BAX: 71.97 (+0.22), PFE: 30.31 (-0.03), BMY: 58.40 (+0.45)
Final Glance: Medical Devices companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.62 (+0.50), JNJ: 108.34 (+0.18), MDT: 69.52 (+0.57), BAX: 71.97 (+0.22)
Geron Collaborates with J&J for Imetelstat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:00PM CST
Geron Corporation (GERN), a clinical-stage biopharmaceutical company, announced that it has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc., a unit of Johnson & Johnson (JNJ).
BIIB: 304.41 (-1.02), JNJ: 108.34 (+0.18), GERN: 3.00 (+0.24), AFFX: 9.27 (-0.44)
Halliburton and Geron are big market movers
AP - Fri Nov 14, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
SINA: 39.51 (-0.29), AMZN: 321.91 (-5.91), JNJ: 108.34 (+0.18), HTZ: 22.10 (+0.41), GERN: 3.00 (+0.24), HAL: 49.59 (-5.49), JWN: 73.22 (-0.95), NOK: 7.67 (-0.19), BHI: 66.06 (+6.17)
Geron's Short Squeeze Is Here
Vahan Avetisyan - Seeking Alpha - Fri Nov 14, 2:40PM CST
Geron' s 2014 D eal to the Rescue Geron (NASDAQ: GERN ) surprised Thursday after-hours when it announced news that it entered into an exclusive worldwide license and collaboration agreement to develop its blood disorder drug imetelstat with...
JNJ: 108.34 (+0.18), GERN: 3.00 (+0.24)
Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:39PM CST
Mallinckrodt (MNK) received a setback when the FDA informed the company that its methylphenidate hydrochloride extended-release tablets, USP (CII) might not be therapeutically equivalent to Johnson & Johnson's (JNJ) Concerta.
MNK: 88.04 (-0.07), BIIB: 304.41 (-1.02), JNJ: 108.34 (+0.18), ACT: 247.01 (+3.24)
Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline
at The Street - Fri Nov 14, 2:36PM CST
U.S. stocks fluctuate on Friday, caught between better-than-expected retail sales and more worries of eurozone deflation.
SINA: 39.51 (-0.29), JNJ: 108.34 (+0.18), HTZ: 22.10 (+0.41), VA: 30.86 (+0.86), GERN: 3.00 (+0.24), JWN: 73.22 (-0.95)
Midday Glance: Pharmaceuticals companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
JNJ: 108.34 (+0.18), BAX: 71.97 (+0.22), PFE: 30.30 (-0.04), BMY: 58.40 (+0.45)
Midday Glance: Medical Devices companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.62 (+0.50), JNJ: 108.34 (+0.18), MDT: 69.52 (+0.57), BAX: 71.97 (+0.22)
(0)
(0)Johnson & Johnson (JNJ) Stock Research Links
Scroll down for more posts ▼